Avantax Advisory Services Inc. Acquires 1,079 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Avantax Advisory Services Inc. raised its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 33.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,305 shares of the company’s stock after acquiring an additional 1,079 shares during the period. Avantax Advisory Services Inc.’s holdings in HCA Healthcare were worth $1,059,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in HCA. RB Capital Management LLC boosted its holdings in shares of HCA Healthcare by 25.9% during the first quarter. RB Capital Management LLC now owns 2,432 shares of the company’s stock worth $610,000 after acquiring an additional 501 shares during the period. American Century Companies Inc. raised its position in shares of HCA Healthcare by 18.6% in the first quarter. American Century Companies Inc. now owns 11,035 shares of the company’s stock valued at $2,766,000 after buying an additional 1,730 shares in the last quarter. Prudential PLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at approximately $1,083,000. Cetera Investment Advisers raised its position in shares of HCA Healthcare by 1.3% in the first quarter. Cetera Investment Advisers now owns 4,499 shares of the company’s stock valued at $1,128,000 after buying an additional 56 shares in the last quarter. Finally, Sequoia Financial Advisors LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at approximately $248,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $305.46 on Friday. The company has a debt-to-equity ratio of 35.07, a current ratio of 1.18 and a quick ratio of 1.02. The stock has a 50-day moving average of $278.31 and a 200-day moving average of $262.99. The company has a market cap of $81.76 billion, a PE ratio of 16.09, a P/E/G ratio of 1.54 and a beta of 1.65. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $314.82.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Tuesday, January 30th. The company reported $5.90 EPS for the quarter, beating the consensus estimate of $5.05 by $0.85. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The company had revenue of $17.30 billion during the quarter, compared to the consensus estimate of $16.51 billion. During the same period last year, the business posted $4.64 EPS. The firm’s revenue for the quarter was up 11.7% compared to the same quarter last year. On average, equities research analysts predict that HCA Healthcare, Inc. will post 20.48 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Friday, March 15th will be given a $0.66 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Thursday, March 14th. This represents a $2.64 annualized dividend and a yield of 0.86%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.64%.

HCA Healthcare announced that its board has approved a share repurchase program on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 7.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of analyst reports. Oppenheimer reiterated an “outperform” rating and issued a $315.00 price target on shares of HCA Healthcare in a research report on Wednesday, January 17th. Cantor Fitzgerald restated an “overweight” rating and set a $315.00 price objective on shares of HCA Healthcare in a research report on Friday, January 19th. Sanford C. Bernstein downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating and upped their price target for the stock from $277.00 to $301.00 in a report on Thursday, January 4th. Wells Fargo & Company lowered their price target on shares of HCA Healthcare from $267.00 to $254.00 and set an “equal weight” rating for the company in a report on Thursday, October 26th. Finally, Citigroup reduced their price objective on shares of HCA Healthcare from $324.00 to $279.00 and set a “buy” rating on the stock in a research note on Wednesday, October 25th. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $304.26.

Read Our Latest Analysis on HCA

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,200 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $306.79, for a total transaction of $981,728.00. Following the transaction, the executive vice president now owns 24,929 shares of the company’s stock, valued at approximately $7,647,967.91. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,200 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $306.79, for a total transaction of $981,728.00. Following the transaction, the executive vice president now owns 24,929 shares of the company’s stock, valued at approximately $7,647,967.91. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Sammie S. Mosier sold 1,645 shares of HCA Healthcare stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $312.00, for a total transaction of $513,240.00. Following the transaction, the senior vice president now directly owns 7,646 shares in the company, valued at approximately $2,385,552. The disclosure for this sale can be found here. In the last quarter, insiders have sold 9,358 shares of company stock valued at $2,883,745. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.